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INTRODUCTION 
The Utinp:a Virus 
In October of 1965 a virus was isolated from the 
blood of the three-toed sloth (Bradypus tridactilus) 
captured in the Utinga Forest near Belem. Serological 
testing of this virus (BE An 84735) against group specific 
immune sera of all presently known viruses of that region 
showed that this agent was serologically related to the 
Simbu group of arboviruses, but was not identical to any 
42 
of the known members of this group. The serological 
relationship of Utinga virus to Oropouche virus of the 
Simbu group was especially interesting, since Oropouche 
had been associated with a large epidemic in Belem during 
the Spring of 1961. Oropouche virus was isolated from 14 
febrile cases, and of the patients studied, 42 of 87 
converted from negative to positive during the epidemic 
with respect to neutralizing antibodies. c The Oropouche 
virus had been isolated from man for the first time in 
Trinidad, a few years prior to the epidemic in Belem.2> 
When the newly isolated agent from the Utinga Forest 
(subsequently named the Utinga virus) was noted to be 
related to Oropouche virus, it became interesting to 
speculate whether it could have played any role in the 
Oropouche epidemic. 
I 
' 
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The study as presented in this paper was undertaken 
with three main objectives in mind: (1) to characterize 
this new agent, the Utinga virus, with respect to its 
serological reactivity and its relationship to the other 
members of the Simbu group of Arboviruses; (2) to obtain 
some idea of the serologic epidemiology of this virus and 
its prevalence; and (3) to find out its possible associa¬ 
tion with the Oropouche virus, whether humans infected with 
Oropouche during an epidemic also develop Utinga antibody, 
and whether it may have played any role in human illnesses 
in the Belem area over the last few years. 
The Arboviruses - G-eneral Consideration 
•Jf 
The arboviruses, arthropod-borne animal viruses, are 
a large heterogeneous group of viral agents linked 
together in classification by their capacity to infect 
certain vertebrates - mammals, reptiles and birds - and to 
multiply in the body of arthropods without producing, with 
rare exceptions, any pathological changes in these infected 
vectors. Such agents are maintained in nature by a 
continuous cycle in which the arthropod vector becomes 
infected, generally by ingesting blood from a vertebrate 
host at a time when the virus circulated in the latter, 
and, after a period of days, designated as the extrinsic 
incubation, the vector, by biting can transmit the disease 
5 1 9 to a new susceptible host. 
* officially accepted nomenclature by the subcommittee on 
virus nomenclature at the International Congress of 
Microbiology, Montreal, August 1962. 
■ 
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Besides the common biological cycle, certain other 
characteristics are probably common to most of these agents: 
(l) an essential lipid envelope making the particle rather 
19.36 
highly sensitive to ether and sodium desoxycholate, 
and (2) an RNA core. Also, they are in general rather 
unstable viruses, readily inactivated by relatively little 
heat (37-57°C), and all produce encephalitis in suckling 
5,19 
mice following intracerebral inoculation. 
To the present time about 220 different arboviruses 
have been isolated in various parts of the world and the 
list is expanding yearly. Through the use of serological 
tests - neutralization (NT), complement-fixation (CF), and 
hemagglutination-inhibition (HI)- most of these viruses 
have now been classified into 22 antigenic groups, 
principally by Casals and co-workers. ^ ^9 <0f 1 1 1 ’ 
Some of these groups also contain subgroups of viruses 
showing very close relationship with each other. 
Although many laboratories and workers around the world 
have contributed to the ever growing list of arbovirus 
isolates, and to the elucidation of the epidemiology of 
these agents, there are several laboratories which have been 
exceptionally productive in this respect. One of these 
laboratories is the Belem Virus Laboratory (Belem, Brazil) 
a field laboratory maintained by the Bockefeller 
Foundation and the Brazilian government since 1954, which 
has been responsible for the isolation of at least 35 new 
IQ 1 1 A ■zrx 
agents and many already known agents. * The 
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functioning of this laboratory is explained, in detail by 
i 2 Causey et al. Over the years this laboratory has 
accumulated a vast number of sera (human, mammal, bird and 
reptile) which provide a wealth of material for retro¬ 
spective serological studies. 
Belem - The Study Area 
Belem and the surrounding area involved in the study, 
as shown in Figure 1, are situated on the right bank of the 
Para River, extending north from the G-uama River to the sea, 
and about 50 inn inland. In this area the climate is 
tropical rain forest, and is characterized by relatively 
high levels of temperature and rainfall, with minimal annual 
variation. The mean monthly temperatures varies less than 
5°C during the year, and the driest month has at least 
1 2 
6.0 cm. of rainfall. 
East of Belem, between 5 and 20 km., is a continuous 
tract of forest along the G-uama River. This is divided into 
the Oriboca virgin forest with many swamps and streams, the 
property of the Instituto Agronomico do Norte (I.A.N.), the 
site of an old cocoa plantation, now reverted to dense 
second growth, and the Utinga forest, a watershed for the 
city reservoirs with several large, deep lakes. 
The Simbu G-rour? 
At the present time 11 different viruses are known in 
the Simbu group of arboviruses, and most of these have been 
t 
* 
. > . 
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isolated only within the last 10 years in various parts of 
the world. Although antibodies in humans have been 
detected for Manzanilla, Simbu, and Oropouche viruses, 
of all the Simbu group viruses only the Oropouche has been 
shown to cause any human disease, and this agent is also 
the only one, other than the Utinga virus, that has been 
isolated in the Belem area. The other members of this 
group, with the dates and location of isolation, and the 
species from which isolated are listed in Table I. 
-Cor Jt 
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MATERIALS AND METHODS 
VIRUSES 
The following Simbu group viruses were used in 
testing: 
Virus Strain Passap;e level 
Akabane Ja Ar 39 18 
Buttonwillow A 7956 5 
Ingwavuma SA An 4165 7 
Manzanilla TRVL 3587 4 
Oropouche TRVL 9760 5 
Sathuperi IG- 111 55 5 
Simbu SA Ar 53 12 
Utinga BE An 84785 3 
Sango lb An 5077 5 
lb An 5550 - 3 
Yaba 7-  
HEMAGGLUTINATION-INHIBITION TESTS 
The major part of the serological survey was done 
employing the hemagglutination-inhibition (HI) test. The 
1 5 
technique used was that described by Clarke and Casals 
with some modifications. 
Preparation of Hemagglutinating Antigens 
The HA antigens were prepared from the brains of 2-4 
day old mice inoculated by the intracerebral route with 
_2 
0.02 ml. of a 10 dilution of stock infectious suckling- 
mouse brains. The mice were harvested (on the eighth day in 
the case of Utinga virus) when some of the mice began to die, 
and many others appeared sick from the infection. The har¬ 
vested mice were kept in polyethylene bags at -70°C until 
ready for use. 
The HA antigen was prepared by the sucrose-acetone 
1 5 
extraction method. This procedure has been used increasingly 
. 
• ) ■ • 
■ 
* 
over the last few years at the Rockefeller Laboratories and 
is proving to be superior to all other methods. 
The removed and weighed suckling-mouse brains were 
homogenized with four volumes of a chilled 8.5$ aqueous 
solution of sucrose, and the homogenate added, by squirting 
from a syringe, to twenty volumes of chilled acetone. This 
mixture was shaken vigorously, and the supernatant decanted. 
The same volume of chilled acetone was added to each bottle, 
and the preparation was allowed to stand in an ice bath for 
one hour. The supernatant was then discarded and the 
sediment dried in a vacuum apparatus. The dry powder was 
rehydrated with 0.85$ saline, the volume used being equal 
to 0.4 of the total volume of homogenate used, and the pre¬ 
paration was left overnight to rehydrate. It was then 
centrifuged for 30 minutes at 10,000 rpm. The supernatant 
was distributed to ampoules (0.5 ml), lyophilized, and the 
ampoules sealed and kept at 4°C until ready for use. 
About 90 ampoules of Utinga antigen were transported, 
without refrigeration during a period of about two weeks, 
to Brazil. Hemagglutination testing upon arrival in 
Brazil demonstrated that in spite of the prolonged 
exposure of the antigen to ambient temperatures, there was 
no loss of titer. In Brazil, the antigen was kept at 4°G 
without loss of titer over 3§ months. 
Sera and Ascitic Fluids 
Most of the mammalian sera examined in the survey 
were obtained from the mammals captured in the Utinga forest, 
, 
, 
■ 
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and most of the bird sera from birds from the I.A.N. area. 
The human sera from 1960—61 were collected from 
inhabitants of several districts of Belem during a 
serological survey for antibodies to the Oropouche virus. 
The human sera from all subsequent years were collected 
from cases of fevers of unknown origin (FUO) which pre¬ 
sented themselves to the laboratory; these were in many 
cases employees of the laboratory and their families. 
Some of these cases were forest workers, many of whom also 
lived in the forest. 
All the sera tested had been stored at the Belem Virus 
Laboratory for various lengths of time (a few days to 
several years) at -20°C or -70°C. 
Reference immune sera and mouse ascitic fluids were 
made by a series of 3 to 5 weekly intraperitoneal 
inoculations in adult mice of 0.1 ml of infected suckling- 
mouse-brain suspension prepared in saline and Freund's 
complete adjuvant (Difco Laboratories). 
After several i.p. inoculations with the antigen, the 
mice were inoculated with 0.1 ml of ascitic fluid from 
mice with ascites secondary to Sarcoma 180/TG-. When these 
mice developed ascites (10-14 days) the ascitic fluid was 
removed using a 50 cc syringe with an 18 G needle. Mice 
that survived this procedure, were paracentesed again at 
intervals of a few days. The ascitic fluid was centri¬ 
fuged for 10 minutes at 10,000 rpm to remove tissue debris, 
and the supernatant fluid was used as reference immune 
ascitic fluid in all subsequent HI, GF, and NT tests. 
. 
■ 
i 
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The Sarcoma 1 80/TG- is a slow-growing strain of the 
tumor which was originally selected for resistance to the 
synergistic antineoplastic drug combination azaserine and 
27 
6-chloropurine. Since it develops more slowly in mice, 
and.'.is much less invasive than the original Sarcoma 180, 
17 38 
as used by Herrmann and Engle and Tikasingh et al, 
considerably larger volumes of ascitic fluid can be 
obtained. The immune ascitic fluids thus produced have 
been shown to have antibody titers which compare very 
favorably with those of the sera from the same mice, and 
27 
to be of high specificity. 
Preparation of Sera for HI Test 
All sera were treated by the acetone extraction method 
1 5 
of Clarke and Casals ' to remove the nonspecific inhibitors 
of arbovirus hemagglutinins, which, as observed by 
24 Porterfield and Rowe , many sera contain. 
Routinely 0.05 ml of serum was treated for all HI 
tests. The serum was diluted 1:10 in 0.85% saline. Using 
a dropper pipette with a #23 disposable needle the serum 
was squirted into 12 volumes chilled acbtone; the prepara¬ 
tion was shaken and allowed to stand in an ice bath for 
five minutes. The tubes were then centrifuged one minute 
at 1,000 rpm, the supernatant decanted, and the precipitate 
resuspended by shaking. An additional 12 volumes of 
acetone was added and the preparation was allowed to 
stand for one hour in an ice bath. The tubes were then 
• 
' 
«* 
* 
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centrifuged 5-8 minutes at 1,500 rpm, the supernatant 
decanted, and the precipitate in the tubes was dried for 
one hour in a vacuum jar at room temperature. The dry 
powder was rehydrated with 0.5 ml. (10 volumes with 
respect to the original volume of serum) of borate-saline 
pH 9.0 solution. This gave a final serum dilution of 1:10 
based on the volume of serum initially introduced. 
23 
Since it has been shown by Porterfield that many 
sera contain naturally occurring agglutinins for goose 
erythrocytes, all sera were routinely absorbed with such 
cells before being used in the tests. The goose 
erythrocytes were obtained by bleeding geese kept at the 
laboratory, with the blood collected in 50 cc syringes with 
acid-citrate-dextrose (AGD). The blood was then centrifuged 
for 10 minutes at 1,000 rpm, the plasma aspirated off by a 
10 cc pipette, and the cells then washed three times with 
saline, each time followed by centrifugation for 10 minutes 
at 1,500 rpm. The final volume of packed cells was diluted 
with 5 volumes of 0.4$ Bovine-albumin in borate-saline (final 
dilution 1:6). 
To each serum (0.5 ml) was added 0.6 ml of the 1:6 
dilution of goose erythrocytes. This preparation was 
allowed to stand for 20 minutes in an ice bath with 
occasional shaking. The tubes were then centrifuged for 
15 minutes at 1,500 rpm, the supernatant decanted, and 
used for the HI tests, the serum at this point being at 
a 1:20 dilution. 

The packed washed goose erythrocytes were also used 
for preparing the cell suspension used in the HI test 
proper. The packed cells were diluted 1:8 with dextrose- 
gelatin- veronal (DGV) and kept as such as a stock 
suspension of cells. By testing the iaemagglutinating 
antigen of the Utinga virus at various pHfs from 6.0 to 
7.0 it was found that the antigen showed optimum agglutina¬ 
tion at pH of approximately 6.4jand therefore this pH was 
used in all subsequent HA and HI tests. The virus¬ 
adjusting-diluent (VAD) solution of the desired pH (or 
approximately 6.4) was prepared by combining phosphate 
buffer solutions of pH 6.0 and pH 7.0 in the proportions 
of 6:4. G-oose cells were added to the VAD solution in the 
proportion of one part cells (at 1:8) per 39 parts diluent 
at the desired pH. This final preparation was used for 
the HA and HI tests. 
Methods for the HA and HI Tests 
All the HA and HI tests were carried out using the 
28 
microtechnic which is based on the modification by Sever 
of a microtitration method originally introduced by 
Takatsy. This micro method has the advantage of facility 
of performance and conservation of reagents and sera. It 
employs small plastic plates with rows of wells (see Figure 
2) in which the reactions are carried out, and calibrated 
wire loops for making the dilutions. 
. 
1 
. 
Preliminary tests using both, the older macro method 
of tube dilutions, and the micro method with loop dilutions 
23 2Q 
confirmed the findings by Sever 1 and Shope J that these 
methods have comparable sensitivities and accuracy. 
All the sera were tested in 1 or 2 dilutions against 
one dilution of antigen adjusted to give about 4 units of 
hemagglutinin per 0.1 ml. The Utinga virus antigen used 
gave 4 units of hemagglutinin at a dilution of 1:4 and this 
was the dilution used for most of the tests. The number 
of units of hemagglutinin is calculated by considering the 
highest dilution of antigen which gives complete or nearly 
complete agglutination as giving one unit of hemagglutinin 
per given volume. 
All dilutions of sera and antigen were made in bovine- 
albumin-borate- saline pH 9.0 solution. 
All components of the test were distributed on the 
plates using a dropper pipette with a blunt 18 gauge needle 
calibrated to give 0.025 ml per drop. 
The acetone treated sera at 1:20 dilution were 
distributed in the wells, and one 24-fold dilution made with 
the wire loops (1:40 dilution). One control well was used 
for each serum to rule out any non-specific goose cell 
agglutinins in the sera. Diluted antigen, giving 4 units 
of hemagglutinin per 0.025 ml was then distributed to all 
the wells except the controls. 
With each test a titration of the antigen was done 
starting with the dilution of the antigen as used for the 
* 
■ 
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test. A control of the diluent was also done with each test, 
to exclude the possibility of non-specific agglutination 
by the diluent. The plates were then incubated overnight 
at 4°C. 
The next day the goose erythrocyte suspensions were 
prepared at pH 6.4 in VAD solution, as explained above, and 
2 drops (0.05 ml) of the cells were added to all the wells 
on the plates. The plates were gently shaken by tapping, 
incubated at 37°G for 45 minutes and read. The plates were 
read as + = complete hemagglutination (no hemagglutination- 
inhibition); + = partial hemagglutination (trace 
hemagglutination-inhibition); ± = trace hemagglutination 
(partial hemagglutination-inhibition); 0 = no 
hemagglutination (complete hemagglutination-inhibition). 
Only sera showing complete inhibition were considered 
positive. All sera giving complete or partial hemagglutin¬ 
ation-inhibition were retested using six serial 2-fold 
dilutions of sera: 1:20 - 1:640. 
NEUTRALIZATION TESTS 
Neutralization tests in micee were carried out to 
substantiate the findings of the HI tests. Gross- 
neutralization tests in mice were performed to further 
elucidate the relationships of the Utinga virus to the other 
members of the Simbu group. 
The neutralization test is based on the principle that 
when a specific immune serum is added to its corresponding 
virus, the virus is rendered noninfective or is "neutralized. 
. 
• • 
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While various animals are used for neutralization tests, 
the Swiss mouse has been found to be a suitable animal for 
work with arboviruses. This animal has the advantage both 
from the standpoint of cost, since for these tests large 
numbers of animals have to be used, and from the stand¬ 
point of host susceptibility, since it has been shown that 
all currently known arboviruses produce infection and 
disease in suckling mice when inoculated by the intra- 
cerebral (IG) route.D’ y This susceptibility was first 
35 demonstrated with yellow fever virus by Theiler in 1930. 
The methods used for the present study were those as 
employed currently at the Yale Arbovirus Research Unit and 
are outlined briefly below. 
The albino Swiss mice, Charles River strain, were 
used exclusively for all tests. Since some agents are 
pathogenic only for the very immature mouse, even by the 
intracerebral route, and since the Utinga virus appears to 
have a fairly long incubation time (about 6-10 days), only 
2-4 day old mice were used. All the baby mice used for 
any one test were pooled together in one box, carefully 
mixed, and distributed back randomly to the individual 
cages, eight mice per cage. 
The constant serum-varying virus method was employed 
for all tests. This method has the advantage that it has 
been more frequently used in vivo, more is known about 
its variables, the end points of titration are rather 
well defined, and it is readily subject to standardization 
. 
' 
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for reference to any constant or index, such as the 
neutralization index. 
The viruses employed were 10$ infectious suckling- 
mice brain in 0.75$ Bovine-albumin-phosphate pH 7.2 (BAP). 
Two types of virus preparations were used. For some of the 
tests a lyophilized preparation of the above was used which 
had been kept in sealed ampoules at -20°C, and was 
rehydrated just prior to use with the appropriate amount 
(0.5 or 1.0 ml) of 0.75$ Bovine-albumine-phosphate pH 7.2. 
Some of the tests were done using a 10$ brain in BAP not 
lyophilized, but kept in sealed ampoules at -70°G. Just 
prior to use the 10$ infectious virus brain preparation 
was rehydrated with 0.75$ BAP, or simply thawed out if the 
frozen material was used, and serial 10-fold dilutions 
made in tubes. 
All the mouse immune ascitic fluids (prepared as 
described previously) which were used for the cross-neutral¬ 
ization tests were stored in lyophilized form in sealed ampoules 
at -20°C. The only exceptions to this were the immune ascitic 
fluid to the Utinga virus and the normal ascitic fluid used 
for controls. These were stored frozen without lyophilization 
in plastic tubes at -20°C. The sera used in the neutralization 
tests done in Belem, and the mouse immune ascitic fluid to 
the Utinga virus used as control in these tests, were stored 
frozen at -20°G. 
Just prior to use, the lyophilized ascitic fluids 
were rehydrated with 0.75$ BAP, and the frozen ascitic 
. 
' 
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fluids or sera thawed out at room temperature. The ascitic 
fluids or sera were then distributed, by pipette to the 
appropriate tubes. An equal volume of the appropriate 
virus dilution was added from the master tubes, and the 
tubes were incubated in a water bath for 60 minutes at 37°C. 
During the time of inoculation the tubes were kept in an ice 
bath. No fresh animal serum (i.e., accessory factor) was 
used. Ascitic fluids were not inactivated. 
Suckling mice (2r4 days old) were inoculated 
intracerebrally with 0.02 ml using 0.25 cc glass tuberculin 
syringes with 26 gauge needles. One cage (8 mice) wa_s 
inoculated with each dilution. The mice were checked 
daily for incidence of illness or death and dead mice were 
discarded. A daily record of morbidity and mortality was 
kept on standard "mouse cards," (See Figure 3.) 
Calculation of the Neutralization Index 
The results of the neutralization and cross¬ 
neutralization tests were calculated on the basis of a 
50 per cent end point expressing a 50 per cent mortality 
or LD^q (50 percent lethal dose). The method of Reed and 
Muench2^ was used for calculating the LD^q and the 
neutralization index. Although this method is applicable 
primarily to a complete titration series, that is, the 
whole reaction range, from 0 per cent to 100 per cent 
mortality, it can be used even when these conditions are 
not fulfilled, if the reactions occur in a uniform manner 
over the range of dilutions employed. 
. 
, 
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A hypothetical arrangement of data used in computing 
the LD50 titer by the Reed-Muench formula is as follows: 
Accumulated Values 
Virus Mortality 
Dilution Died Survived Died Survived Hatio- Per Gent 
10-1 8 0 22 0 22/22 100 
10-2 6 2 14 2 n/16 88 
10-5 5 3 8 5 8/13 1 62 
10-4 5 5 3 10 3/13 23 
10-5 0 8 0 13 0/18 0 
The necessary proportionate distance of the 50 per 
cent mortality end. point is obtained as follows: 
J.% mortality at dilution 
next above 50% - (50/) 
{% mortality at dilution 
next above 50% - {% 
mortality at dilution 
next below 50%) 
= Proportionate Distance 
For the above example the log LP50 = 3.5 
The log neutralization index, in which form the results 
are presented, indicates the capacity of the serum to 
neutralize the action of the virus on the host system 
employed. It represents the difference between the titer 
of the virus in the presence of normal control serum and 
the titer of the virus in the presence of the test serum, 
and is obtained by subtracting the logarithm of the LD^Q 
titer of the immune (or test) serum from the logarithm of 
the LDcjq titer of normal control serum. 
GOHPLEMENT-FIXATION TESTS 
The procedure used for the complement fixation test 
was that employed presently at the Yale Arbovirus Research 
Unit (YARU) and is based on the method described by Casals^4 
o ' OiT 
. 
and 
1 
with the later modifications by Fulton and Dumbell 
by the Rockefeller laboratory. It is a micro method 
employing plastic plates with rows of small wells similar 
to the plates used for the HI tests (see Figure 2), and 
thus has the advantage of conservation of redgents. 
Complement Titration 
Prior to each test the complement was titrated 
using the test tube method (100x13 mra tubes), and again in 
the test itself on the microplates, with the results alway 
in close agreement by both these methods. 
Veronal buffer, pH 7.4, was used for making all the 
dilutions in the test and for controls. In the OF tests 
done at YARU a commercial guinea pig complement was used 
(Baltimore Biological Laboratory, Baltimore, Maryland), 
while in Brazil, frozen pooled guinea pig serum was used 
as the source of complement. 
Fresh complement at a dilution of 1:30, was prepared 
just prior to each test and nine serial dilutions made in 
the following manner: 
hi. 1 2 3 4 5 6 7 9 
3* (1:30)ml. 
Veronal 
D. 1 0.2 0.3 0.35 0.4 0.5 0.6 0.7 0.8 
iiluent ml. 1 .9 1.8 1 .1 1 .65 1 .6 1.5 1.5 1.3 1.2 
Sensitized sheep erythrocytes were prepared by 
combining equal volumes of 4$ sheep erythrocytes (provided 
as either a commercial 10$ sheep cell suspension from 
Baltimore Biological Laboratory or as 10$ erythrocytes 
from sheep kept at the laboratory at Belem) with an equal 
. 
■ 
: ' 
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volume of anti-sheep hemolysin at 1:800 (Baltimore 
Biological Laboratory, Inc. West Chester, Penn.). The 
hemolysin-cell suspension was then incubated for 15 minutes 
in a water bath at 37°C. The sensitized sheep cells were 
prepared in the same manner for both the complement 
titration and for the complement fixation test. 
0.1 ml. of the sensitized sheep cells was added to nine 
tubes containing 0.2 ml of the serially diluted complement 
and 0.1 ml. of veronal diluent. The tubes were incubated 
for 30 minutes in a 37° C water bath:, placed in the 
refrigerator at 4°C for about one hour to allow for complete 
settling in the tubes, and read on a scale of 0 (complete 
hemolysis) to 4 (no hemolysis). On the basis of the 
preliminary complement titration the 1:30 complement 
solution was adjusted to contain 2 units of c* per 0.1 ml 
of 1:30 c*. In practice this adjustment was rarely found 
necessary since the 1:30 c* as prepared, was usually of the 
exact concentration desired. 
Method for the CF Tests 
For the CF test each serum or ascitic fluid was 
diluted to 1:4 with veronal buffer and inactivated, at 
60$C for 20 minutes. Six serial 2-fold dilutions of each 
inactivated serum and of each antigen were made in test 
tubes starting at 1:4. The serum dilutions were distri¬ 
buted on the plates (l drop per well) using dropping 
pippttes with blunt 18 G- needles calibrated to give 0.025 
ml. per drop. One drop of complement (1:30) was added to 
. . 
. 
- 
i 
. 
each well, and then one drop of the antigen dilutions to 
the appropriate wells. With each test a serum control, an 
antigen control and a complement titration were also 
included. The plates were incubated overnight at 4°C, and 
the following morning 1 drop of sensitized sheep 
erythrocytes was added to each well. The plates were 
gently shaken and incubated for 30 minutes at 37-40°C 
with occassional shaking. At the end of this time the 
plates were placed in a refrigerator to allow complete 
settling, and then read on a scale of 0 (complete 
hemolysis) to 4+ (no hemolysis). 
' 
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RESULTS 
CROSS-HI TESTS 
The results of the cross-HI tests of the Utinga virus 
with the other members of the Simbu group are shown in 
Table II. Complete cross-HI testing of all viruses 
against each other was not possible because of the unavail¬ 
ability of hemagglutinating antigens of all the viruses in 
the Simbu group. As far as can be ascertained,some of these 
viruses, including Oropouche, Simbu and Yaba 7 do not 
produce hemagglutinating antigens. Sango, lb An 5550, 
Akabane and Sathuperi do produce HA antigens, but these were 
not available at the time of testing. 
The results in Table Iliare expressed as the 
reciprocal of the highest dilution of immune serum or 
ascitic fluid giving complete inhibition of 4 or 3 units 
of hemagglutinin. The Utinga immune ascitic-fluid gave a 
titer of 1:320 and no other immune ascitic fluid showed 
any inhibition of the Utinga hemagglutinating antigen. 
The Utinga, Manzanilla and Ingwavuma immune ascitic 
fluids showed low titer inhibition of some of the other 
antigens. 
CROSS-CF TESTS 
The results of the cross complement-fixation tests, 
done in conjunction with Dr. R, E. Shope, are shorn in 
Table III. For this testing an Utinga immune ascitic 
.. 
. 
X 
. 
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fluid (BE An 84785 AF, Ii) produced By only one intra- 
peritoneal inoculation of virus with adjuvant, and an 
immune serum (BE An 84784, Ser.3i) produced by three 
inoculations of virus with adjuvant were used. 
The results are expressed as the reciprocal of serum 
dilution/reciprocal of antigen dilution. The Utinga 
ascitic fluid (AF) showed a low-titer reaction in the 
homologous system and no cross reaction with any other 
antigen. The Utinga hyper-immune serum which was anti¬ 
complementary at 1:4 showed a high-titer reaction in the 
homologous system (512/S 256) and with the Oropouche 
antigen (> 128/£ 256), and much less reaction with several 
other antigens. On the other hand the Oropouche immune 
serum reacted at a high titer with its homologous antigen 
(128/64) but showed a relatively low titered reaction with 
the Utinga antigen (8/64). 
CROSS-NT TESTS 
Table IV shows the results of the cross-neutralization 
tests in mice with the Simbu group viruses. The results 
are expressed as the log neutralization index. In the 
homologous systems the Utinga immune AF gave the lowest log 
neutralization index (1.6). The other Simbu group ascitic 
fluids neutralized £ 2.6 log LD^q more of their respective 
homologous viruses than the Utinga virus. 
Testing the Utinga ascitic fluid against all the 
viruses of the Simbu group again showed a log neutralization 
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index with the homologous virus of 1.6 which was one log 
or more greater than the other viruses. 
RESULTS OF SERQLQG-IC SURVEY IN BELEM 
In all, 1336 sera were screened by HI testing for 
antibodies to the Utinga virus. Table V, shows the 
sources of the sera by genus, species and dates when 
obtained. Of 885 sera, excluding the 1961 human sera 
from Belem, only 5 sera showed positive HI reactions at a 
1:20 or greater dilution, Table VI. Two of these sera were 
of insufficient quantity for any further testing,but the 
other three were subjected to neutralization tests in mice 
against the Utinga virus (See Neutralization Tests). 
Four hundred and fifty-one human sera obtained from 
residents cf Belem during the Oropouche epidemic in 1961, 
were tested by HI for antibodies to the Utinga virus. 
Using the antigen which had been prepared at YARU, 18 sera 
were found giving hemagglution inhibition at 1:20 or 
greater dilutions. Of these 18, however, all except one 
(positive at 1:40) failed to inhibit the Utinga antigen 
which was being used at that time by the Belem laboratory. 
This latter antigen had been prepared at the Belem 
laboratory and had a 4-fold higher hemagglutinating titer, 
giving 4 units of hemagglutinin at a 1:16 dilution (cf. 
YARU antigen 4 units of hemagglutinin at 1:4 dilution). 
In these tests the homologous immune serum gave a titer of 
1:80 with the YARU antigen, and 1:160 with the Belem 
antigen. 
^ J>: 
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All the 18 sera were again prepared by the acetone 
extraction method, and retested by HI with both the YARU and 
Belem antigens. This time only 6 of the 13 sera reacted at 
1:20 with the YARU antigen and none reacted with the Belem 
antigen. The homologous immune serum reacted at 1:40 and 
1:80 respectively (cf. 1:80 and 1:160 in first test). 
None of these 18 sera reacted in CF with either 
Oropouche or Utinga antigen. One of the sloth sera which 
had reacted at 1:40 in HI was also tested by CF, and did 
not react with either the Oropouche or Utinga antigens. 
These results are summarized in Table VII. 
NEUTRALIZATION TESTS 
Neutralization tests in mice were performed against 
the Utinga virus with sera from the following sources: 
(1) Sera obtained in 1961 from residents of Belem who had 
experienced febrile illnesses during the Oropouche 
epidemic and from whose blood the virus was Isolated. 
These sera represented the second or third bleedings, 
about 1 or 2 months after the illness, and all neutralized 
and/or reacted in CF tests with Oropouche. None reacted 
in HI with Utinga. (2) Sera from ungulate animals (1 bull, 
3 pigs) which in earlier testing by the Belem Laboratory 
had shown positive HI reactions (at 1:20 or greater) with 
Utinga antigen. Two of these animals had been brought in 
from Marajo Island, across the bay from Belem, one from 
Chaves and one from Porto de Pedro, all areas in close 
proximity to Belem. (3) Sera from the 2 sloths and 1 
' 
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marsupial which had reacted in HI tests with Utinga. (4) 
One serum from a laboratory employee whose serum from 1963 
reacted in HI with Utinga. Since the 1963 sample was of 
insufficient quantity for further testing, a sample 
obtained 2 years later (1965) was used. This sample did 
not react in HI. 
The results of the neutralization tests are shown in 
Table VIII. The Utinga immune ascitic fluid gave a log 
neutralization index £2.4. Of the 4 human sera only one 
(Belem 945) showed a suggestion of neutralization with a 
log neutralization index of 1.6; the other were all 4 1.0. 
The two sloth sera and one pig serum gave log neutralization 
indeces of 1.2, 1.6 and 1.3 respectively and all the other 
sera tested were less than 1.0. 
. . 
. 
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DISCUSSION 
When the Utinga virus was isolated in 1965 the first 
step was to determine whether the isolate was an arbovirus. 
Although the ideal and conclusive evidence for deciding 
that a virus belongs in this family would be the exper¬ 
imental reproduction of the natural cycle, involving the 
virus, host, and vector, this is seldom possible. With the 
Utinga virus this would have been impossible, since as yet 
no vector had been found for this agent. 
Among the considerations which contributed to the 
inclusion of the Utinga virus with the arbovirus group were 
the following: 
1. The virus was isolated from a lower animal, 
captured in a tropical rain forest with abundant 
numbers of arthropods. 
2. It was consistently pathogenic for baby mice. 
43 3. It was inactivated by sodium desoxycholate. 
4. An agglutinin for goose red blood cells was 
demonstrated in infected mouse brain. 
5. It was serologically related to other viruses of 
the Simbu group which are currently considered to 
be arboviruses. 
Pathogenicity for mice, sensitivity to sodium desoxycholate, 
and hemagglutination of goose cells are properties 
7 
common to many arboviruses. Casals considers that the 
finding of a serological relationship to an arbovirus 
4 
. 
. 
. 
. 
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justifies the inclusion of an agent in the arbo "family." 
A logical approach to the classification of arbo¬ 
viruses based on antigenic relationship was first formulated 
by Casals.-?,-y As defined by him, distinct viruses that 
cross-react by one or several serologic tests are considered 
as members of a group, with the understanding that the 
degree of overlap can vary from one extreme, where the 
viruses are nearly indistinguishable, to the other extreme 
in which it is difficult to demonstrate any relationship. 
Viruses are assigned to established groups, or to new 
groups, on the basis of the reactivity of their homologous 
sera with other viruses; the reactivity being due to the 
fact that common antigenic constituents are shared by the 
members of a group. 
Of the serological tests, the HI test with multiple- 
injection sera (or ascitic fluids) has been used most 
widely for classification purposes. Multiple injection 
sera (or AF) are preferred to single-injection sera since 
it has been repeatedly shown that sera from animals given 
several injections of one virus react with a far wider 
spectrum of antigens than do sera produced by a single 
injection.0 The basic value of the HI test for classifi¬ 
cation purposes lies in the fact that, in general, it shows 
a greater width of overlap than either the CF or NT test, 
and in the ease with which it can be carried out in large 
scale. There are cases, however, in which the latter tests 
are more inclusive. With group C^and Bunyamwera10 viruses, 
- for example, the GF test shows a wider overlap than does 
the HI. 
. 
, 
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With the Simbu group it appears that the CF test is 
also more applicable for grouping purposes. For one thing, 
many of the members of this group have not been shown to 
produce hemagglutinating antigens, and secondly, the cross 
reactivity by HI is less than by GF. By GF tests, on the 
other hand, there is significant cross-reactivitjr among 
several of the agents, and by this method the relationship 
between the Utinga and Oropouche viruses wa.s first noted. 
On the basis of Casals’ proposed criteria of classifying 
a new virus in a given group, if it cross-reacts with 
other members of that group, the Utinga virus may thus be 
classified in the Simbu group. It should also be 
re-emphasized that testing of this new agent by the Belem 
Laboratory against reference group sera of the other 
viruses of that region failed to show any antigenic 
similarities. 
On the other hand, the absence of, or very low-titer 
cross reactions of Utinga with the other members of the 
Simbu group by HI, GF and NT testing indicates that this 
new agent is indeed a distinct virus and not simply a new 
strain of one of the other viruses. The results of the 
cross-NT tests are admittedly not completely clear with 
regard to the gres.ter neutralizing capacity of the Utinga 
virus by its homologous serum as compared with the other 
sera (or AF). This may be due to the lack of success in 
producing a hyperimmune Utinga ascitic fluid with a high 
neutralization index. On the other hand, the absence of 
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cross-neutralization between the Utinga and Oropouche 
viruses is in agreement with the results previously noted 
3 
by Bensabath. 
Of the 885 human, mammal and bird sera screened for HI 
antibodies to the Utinga virus only 5 sera (2 sloths, 
1 marsupial, 1 rodent, 1 human) showed low-titer positive 
reactions. The finding of such low-titer reactions is in 
itself not very conclusive evidence of actual infection 
by an agent (for reasons that will be discussed below), and 
it is essential to obtain confirmatory evidence by at 
least one other serological test, although admittedly this 
is not always possible. 
It is generally accepted that NT antibodies remain 
detectable for long periods, especially after clinical 
infection. Less is known about the duration of HI 
antibodies, but apparently they persist considerably 
longer than OF antibodies, and in general the results of 
HI tests usually agree with those of the NT tests. u 
However, when three HI positive sera were tested by 
NT tests, the results were at best equivocal. Whereas in 
that test the homologous hyperimmune ascitic fluid 
neutralized 2 2.4 log LD^q of virus, the 2 sloth sera 
showed log neutralization indices of only 1.2 and 21.6 
respectively, and the marsupial serum only 0.5 or less. 
As inconclusive as these results are, it is interesting 
that these, at least suggestive reactions, were found in 
sloth sera; the sloth being the only animal to date from 
' 
. 
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which the Utinga virus has heen isolated. Also, both of 
these sloths were of the Bradypus tridactilus species. 
However, it should also be noted that one serum from a 
pig (UN 4p) also gave similar inconclusive results. 
JBome of the factors that might explain the above 
results should be considered. It is possible that the 
positive HI reaction may have been due to non-specific 
inhibitors which were not removed by the acetone treatment 
of sera, or that these were expressions of heterologous 
cross-reactions. Such cross-reactions could be due to 
one of the other currently known Simbu group viruses, or 
even to an agent that as 3^et has not been isolated. It is 
even possible, although admittedly less likely, that such 
a cross-reaction could be with agents from a different 
41 8 
arbovirus group. Whitman and Shope, and Casals have 
reported low-grade cross-reactions between arboviruses that 
hitherto have been considered as belonging to distinct 
antigenic groups. 
If, on the other hand, we assume for the moment that 
the HI reactions were specific, what could explain the 
negative, or at best inconclusive, results of the NT tests? 
It is possible that animals simply do not produce high 
titers of NT antibody to Utinga infections. This possibil¬ 
ity is also suggested by the fact that in the cross¬ 
neutralization tests the homologous immune ascitic fluid, 
produced by several inoculations of virus with adjuvant. 
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gave only 1.6 logs of neutralization. 
Another possibility, which has not been ruled out, is 
that either the virus is not easily neutralizable, or that 
"accessory factor" is needed in these reactions. Recently 
differences have arisen concerning the role of the 
"accessory factor." It was noted by Sabin that neutrali¬ 
zation of the mouse-adapted dengue virus by intracerebral 
tests in mice was dependent on two factors - a nonspecific, 
heat-labile accessory substance, and a specific antibody which 
is heat-stable (56°C for 30 min.). Addition of fresh animal 
serum, which in itself has no neutralizing activity, fully 
restored the neutralizing capacity of a heated dengue- 
immune serum. Similar effect have beennnoted for vaccinia 
virus, ^ and Western equine and St. Louis encephalitis 
1 Q immune sera. 2:7 At the same time it appears that at least 
in some instances incubation is mandatory, or virtually so, 
in order to reveal a neutralization effect.^ in their 
p 
report on Oropouche virus, Anderson _et al noted that 
neutralization of this virus was also markedly enhanced by 
the addition of fresh serum, i.e., accessory factor. As 
previously noted, no accessory factor was employed in the 
present NT tests with Utinga. 
The possibility that NT antibodies for Utinga may decay 
faster than HI antibodies should also be considered, although 
this seems less likely. Although it is interesting to 
speculate about the significance of the above results, it 
■ 
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is my opinion that without further confirmatory evidence 
these findings cannot be interpreted as indicative of 
infection with the Utinga virus. 
The results of the HI tests with the Belem human sera 
from 1960-1961 were negative except for a few, low-titered 
reactions. The significance of these low titered reactions 
is difficult to interpret. The lack of consistent, 
reproducible results would seem to indicate that the 
observed reactions were probably due to non-specific 
inhibitors in the sera, rather than to specific antibodies. 
The difference in reactivity of these sera with the Belem 
and YARU antigens cannot be explained at this time. 
As had been noted in the cross-HI, CF, and NT tests 
the relationship of Utinga virus even with Oropouche is 
a limited one. It is found only by the CF test, and 
appears to be a one-way reaction, with the Utinga 
hyperimmune serum reacting with the Oropouche virus but 
not vice-versa,. Thus, the Belem human sera positive by 
CF and NT for Oropouche, did not react with the Utinga 
virus. Here again, some of the factors mentioned, such 
as use of an accessory factor, may be important in 
explaining the difference. 
It thus appears that at least in the species tested, 
the Utinga virus does not seem to be widely distributed. 
The vector responsible for its transmission has not yet 
been identified, and it is possible that the species 
which is its main reservoir has not even been tested. 
. 
Failure to demonstrate antibodies to this virus in the 
large number of human febrile cases that were screened 
suggests that this agent is probably not an important 
factor in human illness in the Belem area. 
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summary 
A newly isolated arbovirus, the Utinga virus, was 
studied to determine some of its serological character¬ 
istics and epidemiology. Cross hemagglutination-inhibition, 
complement-fixation, and neutralization tests established 
that this virus belongs to the Simbu group of Arboviruses, 
cross-reacts by CF with the Oropouche virus but is distinct 
from any of the other members of this group. 
A serological survey of 1336 human, mammalian and 
bird sera from the Belem region of Brazil disclosed only 
5 sera with low-titer positive HI reactions with the 
Utinga antigen, but these could not be confirmed by other 
serologic tests. The absence of antibodies in the human 
sera indicates that this agent probably has not been an 
important factor in human illness in the Belem region. 

TABLES 
and 
FIGURES 

Figure K Map showing location of the Belem study areas 
on the Para and G-uama divers in the State of Para, Brazil0 
Area inclosed within square represents region from which 
all of the sera screened for antibodies to the Utinga 
Virus were obtained. Shaded area represents tropical rain 
forest climate zone. (Map after Causey,et al. Am. J. Trop. 
Med. & H£g., J_0:228, 1961.) 
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Figure 2. A hypothetical arrangement of an HI test on a 
Lucite* plate (Cooke Engineering Company, Alexandria, Va. 
The results as shown are read as follows: 
1 0 = complete hemagglutination-inhibition 
2 Q - partial hemagglutination-inhibition 
3 + = no hemagglutination-inhibition 
clear ). 
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Figure 3. A typical "mouse card" used for recording data 
of neutralization tests in mice. The hypothetical data 
shown is interpreted as follows: 
+ 
? 
S 
Total 
mouse died 
mouse missing from cage, presumed to have died 
and been eaten by mother 
mouse showing obvious evidence of illness 
number of mice surviving on any particular day 
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TABLE IV 
CROSS-NT TESTS WITH SIMBU CROUP VIRUSES* 
Immune Ascitic Fluids 
£ 
VIRUS 
U
ti
n
g
a 
A
ka
ba
ne
 
B
u
tt
o
n
w
il
lo
 
cd 
S 
cd 
£ 
bO 
P M 
Utinga 1 .6 0.6 0.2 1 .0 
Akabane ^0.5 5.3 
Buttonwillow 0.5 >4.7 
Ingwavuma 0.0 2:4.0 
Manzanilla 0.5 
Oropouche 0.6 
Sathuperi o
 
•
 
o
 
S imbu 0.1 
Sango 0.0 
lb An 5550 0.0 
Yaba 7 0.0 
cd o I—I 0) •rl LOi 
H p! Sh LO 
•H o CD LPi 
P p P, o- 
cd o P p o P N ft Xi •oD <3 cd P o P a P PJ 
cd cd •rl cd Pi cd 
S o GO co CO H JH 
0.6 0.6 0.3 
o
 
•
 
o
 
1
 
0.1 
O
 
•
 
o
 O
 
•
 ru
 
3.9 
> 5.2 
5.7 
3.1 
£ 3.7 
2.6 
4.7 
* Results expressed as log neutralization index 
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TABLE V 
Sources of Sera Tested for 
Antibodies to the Utinga Virus 
No. Years No. in 
Source G-enus & Species Tested Represented Each Year 
Marsupials. 
Marmosa sp. 
Marmosa murina 
Metachirus 
nudicaudatus 
Galuromys sp. 
Didelphis 
marsupialis 
Philander opossum 
To 
2 
1 1 
u 
56 
38 
5 
1963 
1965 
1966 
34 
83 
35 
Rodents.... , .219 1965 115 
Oryzomys goeldi "ST 1 966 104 
Proechimys 
guyannenis oris 120 
Nectomys 14 
Echimys 1 
Coendou 1 
Unidentified 2 
Monkeys.... 1963 32 
Cebus 57 1965 44 
Saimiri Sciurus 17 1 966 15 
Tamarin Sp 15 
Howler 2 
Sloths. ,. 88 
Bradypus tridactilus 53 1955-65 - 
Choleopus brasiliensis 11 
Tamandua sp 3 
not identified 21 
Bats. , 21 1963 18 
Unidentified TS 1966 3 
Carollia sp. 1 
Uroderma bilobatum 1 
Artibeus cinereus 1 
Birds. 1 966 171 
Humans. 1960-61 451 
1963 48 
1965 69 
1966 26 
. 
>>• I , ,,,,,,,,,,, 
.. • .... 
■ 
.. ..... . 
.. ..— - .. ... 
...r : 
.... 
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TABLE VI 
Sera Giving Positive HI Reactions 
with Utinga Antigen (Total tested - 885 sera) 
Serum Source 
Date 
Obtained HI titer* 
Ed 78 Sloth 
Brad.ypus tridactilus 5-16-61 40 
Bel 212 
H 57452 
Man 6-24-63 40 
Ed 147 Sloth 
Bradypus tridactilus 1-31-65 20 
Ma 1909 
An 89434 
Marsupial 
Caluromys sp. 7-28-65 20 
Ro 7242 
An 102870 
Rodent^ 
Coendon sp. 6-14-66 20 
* HI titer expressed as reciprocal of highest dilution 
giving complete inhibition. 
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